LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1.

MLA

Sun, Keke, et al. “LINC00152/MiR-139-5p Regulates Gastric Cancer Cell Aerobic Glycolysis by Targeting PRKAA1.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 97, Jan. 2018, pp. 1296–302. EBSCOhost, https://doi.org/10.1016/j.biopha.2017.11.015.

APA

Sun, K., Hu, P., & Xu, F. (2018). LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 97, 1296–1302. https://doi.org/10.1016/j.biopha.2017.11.015

Chicago

Sun, Keke, Pingping Hu, and Feng Xu. 2018. “LINC00152/MiR-139-5p Regulates Gastric Cancer Cell Aerobic Glycolysis by Targeting PRKAA1.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 97 (January): 1296–1302. doi:10.1016/j.biopha.2017.11.015.